Table 4 Glycemic parameters in T2DM patients with obesity (Intra group)

1

HbA1c

Biosimilar Liraglutide

8.4 ± 0.8

7.2 ± 1.9

< 0.001

Reference Liraglutide

8.6 ± 0.8

7.1 ± 2.1

< 0.001

2

FPG

Biosimilar Liraglutide

135.6 ± 38.7

112.6 ± 35.2

< 0.001

Reference Liraglutide

156.1 ± 45.5

118.1 ± 44.1

< 0.001

3

PPBG

Biosimilar Liraglutide

206.5 ± 53.4

166.1 ± 51.9

< 0.001

Reference Liraglutide

233.9 ± 63.7

174.2 ± 61.4

< 0.001